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Abstract
Background: Although molecular pathway information and the International HapMap Project
data can help biomedical researchers to investigate the aetiology of complex diseases more
effectively, such information is missing or insufficient in current genetic association databases. In
addition, only a few of the environmental risk factors are included as gene-environment
interactions, and the risk measures of associations are not indexed in any association databases.
Description: We have developed a published association database (PADB; http://
www.medclue.com/padb) that includes both the genetic associations and the environmental risk
factors available in PubMed database. Each genetic risk factor is linked to a molecular pathway
database and the HapMap database through human gene symbols identified in the abstracts. And
the risk measures such as odds ratios or hazard ratios are extracted automatically from the
abstracts when available. Thus, users can review the association data sorted by the risk measures,
and genetic associations can be grouped by human genes or molecular pathways. The search results
can also be saved to tab-delimited text files for further sorting or analysis. Currently, PADB indexes
more than 1,500,000 PubMed abstracts that include 3442 human genes, 461 molecular pathways
and about 190,000 risk measures ranging from 0.00001 to 4878.9.
Conclusion: PADB is a unique online database of published associations that will serve as a novel
and powerful resource for reviewing and interpreting huge association data of complex human
diseases.
Background
The importance of association databases is ever increasing
and several association databases have been published.
The Genetic Association Database (GAD) [1] is an archive
of published genetic association data, and the Human
Genome Epidemiology (HuGE) Published Literature
Database (HPLD) [2] contains genetic association data
published since October 2000. In addition to these gen-
eral genetic association databases, other databases focus
on the specific areas of genetic associations. For example,
the PharmGKB database [3] specifically assembles phar-
macogenetic information. The AlzGene database [4] cata-
logues genetic association data for Alzheimer's disease
only, and the T1Dbase [5] compiles genetic association
data limited to Type 1 diabetes. On the other hand, the
Cancer Genetic Markers of Susceptibility (CGEMS) [6]
project and the National Institute of Neurological Disor-
ders and Stroke (NINDS) [7] maintain genome-wide asso-
ciation data for Parkinson's disease and prostate cancer,
respectively. And the dbGaP database [8] aims to be the
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although it is in its early stage. However, several important
utilities are missing or insufficient in current genetic asso-
ciation databases. Because most genetic risk factors are
believed to contribute only small influences to the devel-
opment of complex diseases, molecular pathway informa-
tion will prove useful to find a panel of genes that might
operate together in the pathogenesis of a disease [9,10].
And it is also important that any genetic polymorphisms
associated with a biological trait or disease should be care-
fully interpreted in the context of linkage disequilibrium
(LD) between genetic markers to find a causal variant or
gene. Nevertheless, molecular pathway information and
the International HapMap Project [11] data cannot be
effectively accessed from most of genetic association data-
bases. Also, current 'genetic' association databases include
only a few of the 'environmental' risk factors as gene-envi-
ronment interactions, and no database indexes the risk
measures of the associations at present.
Construction and content
Here we describe the development of a published associ-
ation database (PADB; http://www.medclue.com/padb),
which can help biomedical researchers to review genetic
and environmental risk factors more effectively along
with molecular pathway and HapMap information. PADB
indexes sentences containing keywords such as 'case-con-
trol', 'cohort', 'meta-analysis', 'systematic review', 'odds
ratio', 'hazard ratio', 'risk ratio', 'relative risk', or 'associat*'
from PubMed [12] abstracts, which are retrieved using the
National Center for Biotechnology Information (NCBI)
Entrez programming utilities [13]. PADB extracts the odds
ratio, hazard ratio, risk ratio and relative risk measures
automatically if they are available in the sentences. If mul-
tiple associations are reported in a single sentence, they
are indexed as separate records (Figure 1).To expand the
knowledge of genetic association data, PADB automati-
cally identifies the HUGO official symbols of human
genes [14] in the abstracts and links them to various
resources such as the NCBI Entrez Gene database [15], the
University of California Santa Cruz (UCSC) genome
browser [16] and the International HapMap Project data-
base. Thus, genomic annotation data including HapMap
information can be assembled quickly for further analy-
ses. If any gene participates in molecular pathways listed
in the BioCarta [17] or the Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway databases [18], the gene
is linked to those databases through the National Cancer
Institute (NCI) Cancer Genome Anatomy Project (CGAP)
pathway database [19]. In addition, each record of PADB
is linked to the GAD or the HPLD if it is also included in
those databases (Figure 2).
Utility and discussion
Navigating PADB
Users can selectively search four sections of PADB, each
containing genetic associations, pathway associations,
any associations including the risk measures in the
abstract, and all associations. The genetic associations sec-
tion consists of articles containing allele-related terms
such as 'allele', 'genotype', 'haplotype', 'mutation' or 'pol-
ymorphism'. If the genes are constituents of any molecu-
lar pathways listed in the BioCarta or the KEGG pathway
databases, those associations can be searched in the path-
way associations section. When the risk measures are
reported in the abstracts, such associations can be selec-
tively searched and sorted by the risk measures. Finally,
any associations reporting either genetic or non-genetic
environmental risk factors can be searched and sorted by
the publication date. Because PADB searches the input
text as a substring, the search for 'thyroid' retrieves articles
that contain words such as 'thyroiditis', 'parathyroid' and
'hypothyroidism'. The search is case-insensitive and the
search results for 'notch' and 'NOTCH' are same. Also,
users can select one option on how to treat the words
typed in the query text box. The words can be searched
using Boolean terms such as 'AND' or 'OR'. Otherwise, the
words can be searched as a phrase. For example, the search
for 'mood disorder' in 'PHRASE' mode selects those sen-
tences that contain "mood disorder in adults" but not
"mood in bipolar disorder".
Searching for environmental risk factors
The search for 'cadmium' in PADB risk measures section
retrieves 55 risk measures ranging from 0.65 to 10.38, and
16 articles are retrieved in genetic associations section.
The same search failed to retrieve any association from the
GAD and the HPLD, because only a few environmental
risk factors are included as gene-environment interac-
tions. Various non-genetic environmental risk factors
have proved strong risk factors for human diseases and
most gene-environment interactions have probably not
been investigated yet. Thus the search results of environ-
mental risk factors either in the genetic associations sec-
tion or in the risk measures section of PADB will provide
unique and useful information.
Sorting association data by risk measures
Because PADB extracts the risk measure of each associa-
tion, users can sort associations by risk measures.
Although risk measures have become smaller on average
probably thanks to improved study approaches during the
past few decades (Figure 3), sorting by risk measures still
might be useful to characterize or summarize the associa-
tions. For example, the search for 'cancer aspirin' in PADB
risk measures section using 'AND' mode query retrieves
1088 associations reported in 284 abstracts. Among them,
94 abstracts report 208 associations, for which the riskPage 2 of 8
(page number not for citation purposes)
BMC Bioinformatics 2007, 8:348 http://www.biomedcentral.com/1471-2105/8/348measures range from 0.094 to 12.31. As expected, most of
them show that aspirin has been associated with a
reduced risk of colorectal and possibly of other common
cancers. However, besides those protective associations,
some strong risk associations can be identified easily,
because the risk association (RR = 12.31) between aspirin
use and bladder cancer mortality [20] and the raised inci-
dence of kidney cancer (RR = 6.3) among men who took
aspirin daily [21] are presented in the top rows when the
search results are sorted by the risk measures. Those find-
ings might be worth further investigation because the two
risk associations are related to urological cancers. For
another example, cigarette smoking is widely accepted as
a major risk factor for various cancers and there are more
than 2400 published risk measures, ranging from 0.05 to
435.7, in the search results for 'cancer smoking' in PADB
risk measures section using 'AND' mode query. Among
these, several extraordinary protective associations rang-
ing from 0.5 to 0.9 between thyroid cancer and cigarette
smoking [22-26] can be noted quickly and collected,
because they are clustered in bottom rows of the search
results. A similar search for 'BDNF' retrieves 11 risk meas-
ures ranging from 1.0 to 3.81 extracted from six abstracts,
and a search for 'APOE' retrieves 435 risk measures rang-
ing from 0.11 to 33.1 extracted from 227 abstracts. Assem-
bling this kind of information from other databases
would be very difficult.
Expanding the scope of genetic association through 
pathway information
It is unlikely that any single genetic polymorphism would
contribute a single critical effect to complex disease.
Therefore, a pathway-based association study, which
assesses a panel of polymorphisms from the genes in the
same pathway, might be a good approach to find the
causal genetic risk factors more effectively. For example,
different genes in the same inflammatory pathway have
been found to be associated with myocardial infarction
[27,28], and many candidate genes of schizophrenia con-
verge on several specific signalling networks [29-32]. Indi-
viduals with more risk alleles in the nucleotide-excision
repair pathway have more elevated risks of bladder cancer
[33] and several other studies also confirm the potential
of applying such a pathway-based multigenic approach in
association studies [34-37]. However, most genetic associ-
ation studies have investigated only one or a few genes,
and current genetic association databases lack sufficient
molecular pathway information. Because PADB links the
genetic risk factors to comprehensive molecular pathway
information listed in the BioCarta and KEGG databases, it
Sorting associations by the risk measuresFigure 1
Sorting associations by the risk measures. PADB automatically extracts the odds ratio, hazard ratio, risk ratio and rela-
tive risk data if they are available in sentences. When multiple associations are reported in a single sentence, those multiple 
association data are indexed as separate records.Page 3 of 8
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knowledge of genetic associations. For example, the
search for the string 'schizo' in PADB pathway associa-
tions section retrieves numerous pathways related to vari-
ous genes, including NRG1 [38] and EGF [39]. NRG1 is
listed in the BioCarta database as NDF in
'h_ErbB3Pathway' where the neuregulin receptor degrada-
tion protein 1 controls ERBB3 receptor recycling. Because
EGF is listed in the same pathway, the results of independ-
ent studies that report the association of NRG1 and EGF
with schizophrenia can be interpreted based on the con-
vergence of related molecular pathways. Other genes in
the same pathways where NRG1 or EGF participates might
also be good candidates for further investigation of
genetic association with schizophrenia. On the other
hand, 'MAPK signaling pathway' shared by AKT1 and EGF
could be also a good candidate pathway for further stud-
ies. Interestingly, ERBB3 gene participates in both
'h_ErbB3Pathway' and 'MAPK signaling pathway'. Thus,
these evidences might imply an important role of ERBB3
gene in the pathogenesis of schizophrenia. Because the
links are established through automatically identified
human gene symbols, the article "Association of smoking,
CpG island methylator phenotype and V600E BRAF
mutations in colon cancer" is linked to various pathways,
including the 'Alzheimer disease pathway' in which the
BRAF gene is involved. Since more than 45 articles can be
found by the search for 'alzheimer colon cancer' in
PubMed, the connection between 'Alzheimer disease
pathway' and 'colon cancer' through BRAF gene might
imply novel mechanism shared by the two diseases.
Expanding the region of genetic association through 
HapMap information
Any associated genetic markers might be causal alleles or
just strongly linked with the causal allele. For example,
several single nucleotide polymorphisms (SNPs) in IFIH1
region show association with Type 1 diabetes. However,
the associated region contains four genes and there are
strong LDs between SNPs across this region. Thus, we
need additional data to determine which of the four genes
is likely to be the causal locus [40]. Although many
genetic association studies have focussed on non-synony-
mous SNPs, the causal alleles of complex diseases are far
less likely to be missense variations [41]. Indeed, the
Thr17Ala polymorphism in CTLA4 is associated with
autoimmune disease only because it is in strong LD with
a regulatory polymorphism that is more strongly associ-
ated with disease and is therefore more likely to be the
causal allele [42]. Because the HapMap data include the
Linking genetic risks to molecular pathway and HapMap informationFigure 2
Linking genetic risks to molecular pathway and HapMap information. PADB can help biomedical researchers to 
review and interpret genetic risk factors more effectively along with molecular pathway and HapMap information.Page 4 of 8
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quencies of SNPs measured from four ethnic groups, the
target region of any genetic association can be expanded
based on LD. For example, ACSL6 gene was reported to be
associated with schizophrenia [43,44], and these associa-
tions can be retrieved in the search results for 'schizophre-
nia ACSL6' in PADB genetic associations section using
'AND' mode query. The HapMap link of the gene shows
that there is strong LD across a 200 kb genomic region
around ACSL6 gene. Thus, PADB users can easily select
several genes such as IL3 or CSF2, which are good candi-
dates for further genetic association studies due to strong
LD with ACSL6. In fact, multiple SNPs located in and
around IL3 gene were recently found to be associated with
schizophrenia [45].
Comparison with PubMed database
The results of association studies have been reported using
different risk values such as odds ratios, relative risks, haz-
ard ratios or risk ratios, according to the design and anal-
ysis method of the study, and each of them is expressed
exclusively against other measures. Accordingly, the
search results of various keywords related to association
studies in PubMed rarely overlap (Table 1). For example,
the search for 'odds ratio*' in PubMed retrieved 67,815
abstracts (accessed on 30 Nov. 2006) and among them
65,047 (95.9%), 66,998 (98.7%) and 67,238 (99.2%)
abstracts did not contain 'relative risk*', 'hazard ratio*' or
'risk ratio*', respectively; in addition, 50,804 (74.9%) and
56,612 (83.5%) abstracts did not contain 'case-control' or
'cohort*', respectively. By comparison, 75,253 (81.6%)
abstracts out of 92,264 containing 'case-control' and
117,925 (91.3%) abstracts out of 129,128 containing
'cohort*' did not contain 'odds ratio*'. Thus, it would be
a very error-prone task for researchers to capture all of the
relevant articles from PubMed using such a long and com-
plex query process without the aid of an association data-
base such as PADB.
Median risk measures of 'risk' and 'protective' associations during the past 25 yearsFigure 3
Median risk measures of 'risk' and 'protective' associations during the past 25 years. (A) The median strengths of 
risk associations remain quite stable around 2.5 (0.4 when log-transformed) in spite of the exponential increase of published 
association data during the past 25 years. (B) The median strengths of protective associations also remain stable around 0.6 (-
0.2 when log-transformed).Page 5 of 8
(page number not for citation purposes)
BMC Bioinformatics 2007, 8:348 http://www.biomedcentral.com/1471-2105/8/348Comparison with other association databases
The GAD and the HPLD contain only a few environmen-
tal risk factors as gene-environment interactions, as dis-
cussed above. Furthermore, the pathway database links
provided by the GAD seldom work and the HPLD does
not provide any links to the pathway databases. Because
the HPLD uses a controlled vocabulary, the search results
for 'stroke' successfully include related terms such as 'cer-
ebrovascular disease' and 'transient ischemic attack'.
However, the users cannot search for terms such as
'rs4680' or 'Chinese' in the abstract because they are not
included in the standard vocabulary. The PharmGKB
database specifically focuses on the pharmacogenetic
association data only and also lacks environmental fac-
tors. The Cochrane Database of Systematic Reviews offers
only systematic reviews, and genetic associations are sel-
dom reviewed. Although the AlzGene database and the
T1Dbase have many excellent features, including meta-
analysis or microarray data, each database covers only one
specific disease. Recently, genome-wide association data-
bases such as CGEMS, NINDS and dbGaP have been
introduced. Because these databases store the results of
genome-wide association studies on a specific disease,
they also differ from general association databases such as
PADB, GAD and HPLD (Table 2).
Conclusion
PADB is a unique online database of published associa-
tion data. As it automatically collects and updates associ-
ation data directly from PubMed database, it is
comprehensive and up-to-date. PADB covers both genetic
and environmental risk factors, along with molecular
Table 2: Comparison of association databases


























PADB O O O O X X X O O O
GAD O Partial O O X Partial X X O O
HPLD O Partial O Partial O Partial X X X X
Cochrane Partial O O O X O O X X X
AlzGene O X X O X O O X X X
T1DBase O X X O X X X X X O
PharmGK
B
O X X O Partial X X X X O
CGEMS O X X X X O O X X X
NINDS O X X X X O O X X X
dbGaP O X X X X O O X X X
PADB was compared with other association databases, including those for general associations (GAD, HPLD and the Cochrane Reviews), genetic 
associations for specific diseases (AlzGene, T1Dbase and PharmGKB) and genome-wide associations (CGEMS, NINDS and dbGaP).
Table 1: PubMed search results of various query terms related to association studies
















odds ratio* 67,815 - 65,047 66,898 67,238 50,804 56,612 24,427
relative risk* 32,280 29,512 - 31,944 31,830 27,878 24,374 14,907
hazard ratio* 8,927 8,110 8,591 - 8,868 8,598 5,848 3,548
risk ratio* 3,694 3,117 3,244 3,535 - 3,377 2,814 1,841
case-control 92,264 75,253 87,862 91,935 91,947 - 83,109 50,155
cohort* 129,128 117,925 121,222 126,049 128,248 119,973 - 75,875
associa* 1,591,541 1,548,153 1,574,168 1,586,162 1,589,688 1,549,432 1,538,288 -
The search results for various keywords related to association studies in PubMed seldom overlap. The search for 'odds ratio*' in PubMed retrieved 
67,815 abstracts when accessed on 30 November 2006. Among these, 65,047 (95.9%), 66,998 (98.7%) and 67,238 (99.2%) abstracts did not contain 
'relative risk*', 'hazard ratio*' or 'risk ratio*', respectively. Moreover, 50,804 (74.9%) and 56,612 (83.5%) abstracts did not contain 'case-control' or 
'cohort*', respectively. By comparison, 75,253 (81.6%) abstracts out of 92,264 containing 'case-control' and 117,925 (91.3%) abstracts out of 
129,128 containing 'cohort*' did not contain 'odds ratio*'.Page 6 of 8
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as a novel and powerful resource for reviewing and inter-
preting disease association data.
Availability and requirements
Project name: Published Association Database
Project home page: http://www.medclue.com/padb/
Operating system: Linux
Programming language: Perl and Pascal
Licence: the database is freely accessible for academic
users under the GNU GPL.
Restrictions to use by non-academics: commercial users
are referred to the developers of PubMed, Entrez Gene,
CGAP Gene, UCSC Genome Browser, HapMap Project,
BioCarta, KEGG, GAD and HPLD databases for more
details on access.
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